by Hiroshima University Scientists from Hiroshima University and University of California, San Diego have discovered the mechanism by which EGFR activates YAP/TAZ. Their results suggest that the combination of the drug targeting YAP/TAZ with EGFR targeting therapy may be beneficial for preventing cancer recurrence and progression acquired by YAP/TAZ re-activation through unknown mechanism. Credit: Toshinori...
